Reactive arthritis in the right hip following COVID-19 infection: a case report
Tropical Diseases, Travel Medicine and Vaccines, 2021 Background SARS-COV-2 usually presents with respiratory symptoms but can have various other manifestations and sequelae. One of the rare complications of COVID-19 infection is Reactive Arthritis.
Kamyar Shokraee +4 more
doaj +1 more source
Immune-mediated inflammation promotes subclinical atherosclerosis in recent-onset psoriatic arthritis patients without conventional cardiovascular risk factors [PDF]
, 2018 Studies on the inflammatory burden in recent-onset psoriatic arthritis (PsA) patients without conventional cardiovascular risk factors (CVRFs) are not available.
Capani, Francisco +8 more
core +1 more source
Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions. [PDF]
, 2020 ObjectiveTo evaluate whether biologic disease-modifying antirheumatic drugs (DMARDs) decrease cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) and whether biologic DMARDs might have a beneficial effect on coronary plaque formation or ...
Budoff, Matthew J +3 more
core +1 more source
Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. [PDF]
, 2014 BackgroundIndividuals with rheumatoid arthritis (RA) are at increased risk for cardiovascular disease, partly due to systemic inflammation and endothelial dysfunction.
Del Puerto, Gus +10 more
core +2 more sources
Adult-onset poststreptococcal reactive arthritis: a case report [PDF]
Xin yixue, 2023 Poststreptococcal reactive arthritis （PSRA） refers to reactive arthritis after Group A streptococcal （GAS） infection that does not meet the diagnostic criteria for acute rheumatic fever （ARF）. It is rare in clinical practice and prone to misdiagnosis due
Wu Zongyu, Chen Chuping, Chen Guangshu, Luo Lihui, Xiong Xiaoqing, Liu Wei, Ran Jianmin
doaj +1 more source
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study [PDF]
, 2015 Objective: To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA).
Bonin, Randi +15 more
core +1 more source
Quantification of IFNγ- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patients [PDF]
, 2013 Antibodies against citrullinated proteins are highly specific for rheumatoid arthritis (RA) and are currently used as a diagnostic marker. In this study, we wanted to quantify the numbers of T cells that react to a wide range of citrullinated proteins in
De Ceuleneer, Marlies +5 more
core +1 more source
Shigella Draft Genome Sequences: Resources for Food Safety and Public Health. [PDF]
, 2017 Shigella is a major foodborne pathogen that infects humans and nonhuman primates and is the major cause of dysentery and reactive arthritis worldwide. This is the initial public release of 16 Shigella genome sequences from four species sequenced as part ...
Chen, Poyin +5 more
core +1 more source
Reactive arthritis – an interdisciplinary issue
Przegląd Dermatologiczny, 2019 Reactive arthritis is an aseptic inflammation of synovium, tendons and fasciae triggered by an immunological reaction to a distant-site infection. It is usually asymmetric.
Ewelina Biało-Wójcicka +2 more
doaj +1 more source
Reactive arthritis after SARS-CoV-2 infection
RMD Open, 2022 SARS-CoV-2 has been recognised as a potential trigger of inflammatory arthritis in individuals with inflammatory rheumatic diseases as well as in previously unaffected individuals. However, new-onset arthritis after COVID-19 is a heterogeneous phenomenon
Alla Skapenko, Sophia Dombret
doaj +1 more source